General Purpose
Active
ID: 1272633
·
First filed: May 22, 2006
California Life Sciences Political Action Committee
View
Receipt Summary
| Source Type | Distribution | Amount | Percentage |
|---|---|---|---|
| Other | $2.26M | 94.1% | |
| Committee | $80.3K | 3.3% | |
| Individual | $62K | 2.6% | |
| Total | $2.41M | 100% |
Receipts
| Donor | Total Amount | % of Total | |
|---|---|---|---|
|
Johnson and Johnson Corporate Political Fund
Other
|
0.2% | ||
|
Wendye Robbins
President & Ceo at Blade Therapeutics
|
0.2% | ||
|
Ligand Pharmaceuticals
Other
|
0.2% | ||
|
Abbvie Inc.
Other
|
0.2% | ||
|
Coherus Biosciences, Inc.
Other
|
0.2% | ||
|
Jazz Pharmaceuticals, Inc.
Other
|
0.2% | ||
|
Genomic Health, Inc.
Other
|
0.2% | ||
|
Danaher Corporation
Other
|
0.2% | ||
|
Oncomed Pharmaceuticals
Other
|
0.2% | ||
|
Cytokinetics Inc.
Other
|
0.2% | ||
|
Arena Pharmaceuticals
Other
|
0.2% | ||
|
Santa Cruz Nutritionals
Other
|
0.2% | ||
|
Twist Bioscience Corporation
Other
|
0.2% | ||
|
Elan Pharmaceuticals
Other
|
0.2% | ||
|
Alexandria Real Estate Equities, Inc.
Other
|
0.2% | ||
|
Veracyte, Inc.
Other
|
0.2% | ||
|
Sutro Biopharma, Inc.
Other
|
0.1% | ||
|
Ardelyx, Inc.
Other
|
0.1% | ||
|
Actelion Pharmaceuticals Us, Inc.
Other
|
0.1% | ||
|
Onyx Pharmaceuticals, Inc.
Other
|
0.1% | ||
|
Cytomx Therapeutics, Inc.
Other
|
0.1% | ||
|
Merck & Company
Other
|
0.1% | ||
|
Aon Insurance
Other
|
0.1% | ||
|
Nektar Therapeutics
Other
|
0.1% | ||
|
Irhythm Technologies
Other
|
0.1% |